Home Cart Sign in  
Chemical Structure| 79350-37-1 Chemical Structure| 79350-37-1

Structure of Cefixime
CAS No.: 79350-37-1

Chemical Structure| 79350-37-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Cefixime is a third-generation cephalosporin antibiotic which is highly stable in the presence of β-lactamase enzymes.

Synonyms: FK-027; FR-17027; Trihydrate, Cefixime

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Cefixime

CAS No. :79350-37-1
Formula : C16H15N5O7S2
M.W : 453.45
SMILES Code : O=C(O)C(N1[C@@]([H])([C@@H](C1=O)NC(/C(C2=CSC(N)=N2)=N\OCC(O)=O)=O)SC3)=C3C=C
Synonyms :
FK-027; FR-17027; Trihydrate, Cefixime
MDL No. :MFCD00865020
InChI Key :OKBVVJOGVLARMR-QSWIMTSFSA-N
Pubchem ID :5362065

Safety of Cefixime

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H317-H334
Precautionary Statements:P261-P272-P280-P284-P302+P352-P304+P340+P312

Isoform Comparison

Biological Activity

Description
Cefixime (FR-17027) is an orally active third-generation cephalosporin antibiotic, effective for treating various bacterial infections[1].[2].

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00926796 Gonorrhoea Phase 4 Completed - United States, Alabama ... More >> University of Alabama Hospital - Infectious Diseases Birmingham, Alabama, United States, 35249-0001 United States, California Los Angeles County Department of Public Health - Sexually Transmitted Disease Program Los Angeles, California, United States, 90007-2608 San Francisco Department of Public Health - San Francisco City Clinic San Francisco, California, United States, 94103-4030 United States, Maryland Johns Hopkins Bayview Medical Center - Infectious Diseases Baltimore, Maryland, United States, 21224-2735 United States, Pennsylvania Magee Women's Hospital of UPMC - Reproductive Infectious Disease Research Pittsburgh, Pennsylvania, United States, 15213-3108 Less <<
NCT00926796 - Completed - -
NCT02099240 Osteomyelitis Early Phase 1 Recruiting September 2019 United States, Kentucky ... More >> University of Louisville Recruiting Louisville, Kentucky, United States, 40202 Contact: Julio A Ramirez, MD    502-852-1148    jarami01@louisville.edu    Contact: David Seligson, MD    502-852-0923    d0seli01@louisville.edu    Sub-Investigator: Forest Arnold, DO          Sub-Investigator: Timothy Wiemkwn, PhD          Sub-Investigator: Robert Kelley, PhD          Sub-Investigator: James Summersgill, PhD          Sub-Investigator: Ruth Carrico, PhD          Sub-Investigator: Julie Harting, PharmD          Sub-Investigator: Paula Peyrani, MD          Principal Investigator: David Seligson, MD          Sub-Investigator: Craig Roberts, MD          Principal Investigator: Julio Ramirez, MD Less <<
NCT01734759 Healthy Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT01665690 Gonorrhea Nei... More >>sseria Gonorrhoeae Chlamydia Trachomatis Less << Phase 4 Completed - United States, Washington ... More >> Washington State Department of Health Olympia, Washington, United States, 98504-7890 University of Washington Seattle, Washington, United States, 98104 Less <<
NCT00004216 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Texas Mary Crowley Medical Research Center Dallas, Texas, United States, 75246 Less <<
NCT01720654 Gonorrhea Chl... More >>amydia Less << Not Applicable Completed - Peru ... More >> Asociacion Civil Impacta Salud y Educacion Lima, Peru Less <<
NCT01388413 Neurogenic Bladder ... More >> Urinary Tract Infection Less << Phase 4 Completed - France ... More >> University Hospital, Raymond Poincaré / APHP Garches, France, 92380 University Hospital, St Jacques / NANTES Nantes, France, 44000 University Hospital, Pontchaillou / RENNES Rennes, France, 35000 University Hospital, Bretonneau / TOURS Tours, France, 37000 Less <<
NCT02021006 Vesicoureteral Reflux ... More >> Renal Hypodysplasia, Nonsyndromic, 1 Chronic Kidney Disease Less << Phase 3 Recruiting December 2021 Italy ... More >> Pediatric Nephrology Dialysis and Transplant Unit IRCCS Ca'Granda Recruiting Milan, Italy, 20122 Contact: Giovanni Montini, Professor    +390255032336    giovanni.montini@unimi.it    Principal Investigator: Giovanni Montini, Professor Less <<
NCT00644696 Neuroblastoma Phase 1 Completed - United States, Michigan ... More >> The University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT02224040 Typhoid Fever Phase 4 Unknown August 2015 Nepal ... More >> Dhulikhel hospital Recruiting Dhulikhel, Nepal, 11008 Contact: Sudeep Shrestha, M.D       itsactionpotential@gmail.com Less <<
NCT03084601 Necrotic Pulp ... More >> Postoperative Pain Less << Phase 4 Completed - Egypt ... More >> Pedodontic Department Cairo University Cairo Governorate, Cairo, Egypt, 002 Less <<
NCT00186979 Solid Tumors Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT02035137 Neuroblastoma Phase 2 Recruiting December 2019 United States, California ... More >> Childrens Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027-0700 Contact: Araz Marachelian, MD    323-361-5687    amarachelian@chla.usc.edu    Lucile Salter Packer Children's Hospital Recruiting Palo Alto, California, United States, 94304 Contact: Sheri Spunt, MD          UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94115 Contact: Katherine Matthay, MD    415-476-3831    matthayK@peds.ucsf.edu    United States, Colorado Children Hospital of Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Margaret Macy, MD    720-777-8856    Margaret.macy@childrenscolorado.org    United States, Georgia AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus Recruiting Atlanta, Georgia, United States, 30322 Contact: Kelly Goldsmith, MD    404-785-0853    kgoldsm@emory.edu    United States, Illinois University of Chicago, Comer Children's Hospital Recruiting Chicago, Illinois, United States, 60637 Contact: Ami Desai, MD    773-843-3943    adesai12@peds.bsd.uchicago.edu    United States, Massachusetts Children's Hospital Boston Recruiting Boston, Massachusetts, United States, 02115 Contact: Suzanne Shusterman, MD    617-632-4901       United States, Michigan C.S Mott Children's Hospital Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Gregory Yanik, MD    734-936-8785    gyanik@umich.edu    United States, North Carolina University of North Carolina Not yet recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Patrick Thompson, MD       patom@email.unc.edu    United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229-3039 Contact: Brian Weiss, MD    513-636-9863    brian.weiss@chmcc.org    United States, Pennsylvania Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104-4318 Contact: Yael Mosse, MD    215-590-0965    mosse@chop.edu    United States, Texas Cook Children's Healthcare System Recruiting Fort Worth, Texas, United States, 76104 Contact: Meaghan Granger, MD    682-885-4007       United States, Washington Seattle Children's Hospital Recruiting Seattle, Washington, United States, 98105 Contact: Navin Pinto, MD    206-987-5783    navin.pinto@seattlechildrens.org    Canada, Ontario Hospital for Sick Children Recruiting Toronto, Ontario, Canada, M5G1X8 Contact: Meredith Irwin, MD Less <<
NCT03716804 Uncomplicated Urinary Tract In... More >>fection Antibiotic Resistant Infection Less << Phase 4 Recruiting January 25, 2019 Bangladesh ... More >> Combined Military Hosptal, Dhaka Recruiting Dhaka, Bangladesh Contact: Abdul Quddus Bhuiyan, MBBS, FCPS    1673615641 ext +880 Less <<
NCT01595529 Urinary Tract Infection Phase 2 Recruiting December 31, 2019 United States, Pennsylvania ... More >> Children's Hospital of Pittsburgh of UPMC - General Academic Pediatric Recruiting Pittsburgh, Pennsylvania, United States, 15213-3205 Less <<
NCT02830230 Cervical Inflammation and Huma... More >>n Papilloma Virus Performance Less << Not Applicable Unknown July 2018 India ... More >> Tata Memorial Hospital Not yet recruiting Mumbai, Maharashtra, India, 400012 Contact: Sharmila A Pimple, MD    91-2224154379    drsharmilapatil@yahoo.com    Contact: Kavita V Anand, DGO    9892191968    drkavitaanand@gmail.com Less <<
NCT01390623 Acute Uncomplicated Pyelonephr... More >>itis Less << Phase 4 Completed - France ... More >> CHU de Clermont-Ferrand Clermont-Ferrand, France, 63003 Less <<
NCT00786669 Solid Tumor Phase 1 Completed - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT00136656 Pyelonephritis Phase 4 Completed - France ... More >> Hopital de Bicetre Bicetre, France, 94275 Hopital Pellegrin Bordeaux, France, 33000 Hôpital Ambroise Pare Boulogne, France, 92100 Hôpital Antoine Beclere Clamart, France, 92141 Chu de Limoges Limoges, France, 87042 La Timone Marseille, France, 13385 CHU NICE Nice, France, 06000 Saint Vincent de Paul Paris, France, 75014 Necker Enfants Malades Paris, France, 75015 Robert Debre Paris, France, 75019 Hôpital Armand Trousseau Paris, France, 75571 Hopital Andre Mignot Versailles, France, 78150 Less <<
NCT02596503 Relapsed Solid Tumors ... More >> Refractory Solid Tumors Less << Phase 1 Recruiting September 2020 United States, Colorado ... More >> Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Carrye Cost, MD    720-777-6775    Carrye.Cost@childrenscolorado.org    Contact: Debra Schissel, RN    720-777-2879    Debra.Schissel@childrenscolorado.org    Principal Investigator: Carrye Cost, MD          Sub-Investigator: Margaret Macy, MD          Sub-Investigator: Lia Gore, MD          United States, Kentucky University of Kentucky Recruiting Lexington, Kentucky, United States, 40536 Contact: Tom Badgett, MD, PhD    859-218-0332    tom.badgett@uky.edu    Contact: Tammy Taylor, RN    859-323-6975    tammy.taylor@uky.edu    Sub-Investigator: Lars Wagner, MD          Sub-Investigator: Markos Leggas, PhD          Principal Investigator: Tom Badgett, MD PhD          United States, Texas University of Texas, Southwestern Medical Center Recruiting Dallas, Texas, United States Less <<
NCT00093353 Diarrhea Drug... More >>/Agent Toxicity by Tissue/Organ Neuroblastoma Less << Phase 1 Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States, 94304 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Georgia AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus Atlanta, Georgia, United States, 30322 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0718 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas Texas Children's Cancer Center and Hematology Service at Texas Children's Hospital Houston, Texas, United States, 77030-2399 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Less <<
NCT01072136 Vaginitis Bacterial ... More >> Cervicitis Less << Phase 3 Terminated - United States, Alabama ... More >> University of Alabama Hospital - Infectious Diseases Birmingham, Alabama, United States, 35249-0001 United States, California Harbor UCLA Medical Center - OBGYN - General Gynecology and Women's Health Torrance, California, United States, 90502-2006 United States, Louisiana Louisiana Stte University - Health Sciences Center - Medicine New Orleans, Louisiana, United States, 70112-1349 United States, Mississippi University of Mississippi - Infectious Diseases Jackson, Mississippi, United States, 39216-4505 Less <<
NCT01072136 - Terminated - -
NCT03408392 Infections, Bacterial Phase 1 Completed - South Africa ... More >> GSK Investigational Site Bloemfontein, Free State, South Africa, 9300 Less <<
NCT01949363 Gonorrhoea PHASE1 COMPLETED 2025-12-15 Johns Hopkins Bayview Medical ... More >>Center - Infectious Diseases, Baltimore, Maryland, 21224-2735, United States Less <<
NCT02708992 Gonorrhoea Phase 1 Completed - United States, North Carolina ... More >> Duke University School of Medicine - Duke Clinical Research Institute - Duke Clinical Research Unit Durham, North Carolina, United States, 27710-4000 Less <<
NCT03660488 Syphilis Earl... More >>y Syphilis Less << Phase 2 Recruiting October 2020 United States, California ... More >> AHF Westside Recruiting Beverly Hills, California, United States, 90211 Contact: Carl Millner, MD       carl.Millner@aidshealth.org    AHF Downtown Healthcare Center Recruiting Los Angeles, California, United States, 90015 Contact: David Tellalian, MD       david.tellalian@aidshealth.org    AHF Carl Bean Recruiting Los Angeles, California, United States, 90018 Contact: David Tellalian, MD          AHF Hollywood Healthcare Center Recruiting Los Angeles, California, United States, 90027 Contact: Pam Burian, PA    323-662-0492    Pamela.Burian@aidshealth.org    AHF Wellness on Western Center Recruiting Los Angeles, California, United States, 90027 Contact: Cliff Okada, MD       cliff.Okada@aidshealth.org    AHF Oakland Wellness Center Recruiting Oakland, California, United States, 94606 Contact: Christopher Mejia, MPH    510-628-0949    Christopher.mejia@aidshealth.org    AHF Healthcare Center Oakland Recruiting Oakland, California, United States, 94609 Contact: Seth Glassman, MD       seth.glassman@aidshealth.org    AHF San Francisco Recruiting San Francisco, California, United States, 94114 Contact: Seth Glassman, MD       seth.glassman@aidshealth.org    AHF Valley Recruiting Sherman Oaks, California, United States, 91403 Contact: James Carroll, MD       james.carroll@aidshealth.org    United States, Nevada AHF Las Vegas Healthcare Center Recruiting Las Vegas, Nevada, United States, 89109 Contact: Warren Magnus, MD       warren.magnus@aidshealth.org Less <<
NCT03752112 Syphilis Female Phase 1 Phase 2 Not yet recruiting February 1, 2021 Brazil ... More >> Fortaleza University Not yet recruiting Fortaleza, Ceara, Brazil Contact: Alix Araujo, PhD       alix.araujo@hotmail.com    Contact: Ivo Castell Branco Coelho, MD       ivo@ufc.br    Principal Investigator: Alix Araujo, PhD          Principal Investigator: Mariangela Silveira, MD          Principal Investigator: Angelica Miranda, MD Less <<
NCT03329547 Infections, Bacterial Phase 1 Withdrawn(Change in commercial... More >> strategy) Less << February 2, 2018 -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.21mL

0.44mL

0.22mL

11.03mL

2.21mL

1.10mL

22.05mL

4.41mL

2.21mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories